Senior insider sale
SVP, Chief Accounting Officer at VIR BIOTECHNOLOGY, INC. — senior position signals high conviction
$109.5K
12.50K shares
What this filing means
SABATINI BRENT plans to sell 12.50K shares of VIR BIOTECHNOLOGY, INC. valued at approximately $109.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/23/2026ACC: 0001959173-26-002551
Officer· SVP, Chief Accounting Officer
Since Feb 2026
12.50K
Shares to sell
$109.5K
Approx. market value
7.71K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months3
Restricted Stock Vesting
Compensation
2/24/2026
2.94KRestricted Stock Vesting
Compensation
2/23/2026
2.55KRestricted Stock Vesting
Compensation
2/13/2026
2.22KTotal acquired7.71K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/24/2026 | Restricted Stock Vesting Compensation | 2.94K | — |
2/23/2026 | Restricted Stock Vesting Compensation | 2.55K | — |
2/13/2026 | Restricted Stock Vesting Compensation | 2.22K | — |
| Total | 7.71K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
1.43K
Market value
$13.6K
2/24/2026
—Completed
Units to sell
1.83K
Market value
$13.6K
2/23/2026
—Completed
Units to sell
1.53K
Market value
$11.9K
2/13/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.71K
Market value
$70.3K
3/23/2026
Total
Units
12.50K
Value
$109.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/24/2026 | 1.43K | $13.6K | — | Completed |
2/23/2026 | 1.83K | $13.6K | — | Completed |
2/13/2026 | 1.53K | $11.9K | — | Completed |
| Planned — Approximate Date | ||||
3/23/2026 | 7.71K | $70.3K | NASDAQ | Planned |
| Total | 12.50K | $109.5K | ||